Quantcast
Last updated on April 16, 2014 at 12:01 EDT

Latest Antiretroviral drug Stories

2013-01-22 10:42:06

Studies suggest new approach to treating HIV A team of researchers based at Johns Hopkins has decoded a system that makes certain types of immune cells impervious to HIV infection. The system's two vital components are high levels of a molecule that becomes embedded in viral DNA like a code written in invisible ink, and an enzyme that, when it reads the code, switches from repairing the DNA to chopping it up into unusable pieces. The researchers, who report the find in the Jan. 21 early...

2013-01-17 13:38:06

A 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need for long term treatment, according to research published today in the New England Journal of Medicine. However, the delay was only marginally longer than the time already spent on treatment. The study, the largest clinical trial ever undertaken looking at treating people with recent HIV infection, also suggests that the treatment lowers the...

2013-01-17 13:30:25

Earlier therapy enhances restoration of CD4+ T-cell counts Patients who are started on antiretroviral therapy for HIV-1 infection within four months of estimated infection date – and who have higher counts of CD4+ T-cells at the initiation of therapy – demonstrate a stronger recovery of CD4+ T-cell counts than patients in whom therapy is started later, a new study shows. The report, to be published Thursday in The New England Journal of Medicine, is co-authored by physicians...

Billions Saved With Generic HIV Medication
2013-01-15 18:45:18

Lee Rannals for redOrbit.com — Your Universe Online Replacing brand-name, antiretroviral drugs recommended for control of HIV infection with generic medications could save nearly $1 billion a year on health care costs in the US. This strategy of replacing the brand-name drugs with the soon-to-be-available generic drugs could also come with its risks, diminishing the efficacy of the HIV treatment. "The switch from branded to generic antiretrovirals would place us in the...

2013-01-02 16:22:49

Amazon tree-derived medicine cleared for usage in HIV patients with diarrhea AUSTIN, Texas, Jan. 2, 2013 /PRNewswire-USNewswire/ -- The following is being released by the American Botanical Council: (Logo: http://photos.prnewswire.com/prnh/20100430/DC95601LOGO) On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq(TM), Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) -- marking the second time a botanical, and the first...

2012-12-19 15:10:45

Findings emphasize importance of patient counseling to stop smoking in integrated HIV care Among HIV patients receiving well-organized care with free access to antiretroviral therapy, those who smoke lose more years of life to smoking than to HIV, according to a Danish study published in Clinical Infectious Diseases and available online. The findings highlight the importance of smoking cessation efforts in the long-term, integrated care of patients infected with HIV. Marie Helleberg,...

HIV Drug May Help Fight Against Deadly Staph Infection
2012-12-16 07:11:52

redOrbit Staff & Wire Reports - Your Universe Online Potentially deadly staph infections could be treated with a drug currently used by those who have been infected by HIV, according to researchers from the New York University (NYU) School of Medicine. In the study, senior author and NYU assistant professor of microbiology Dr. Victor J. Torres and colleagues discovered that maraviroc, an antiretroviral drug used to treat those who have contracted the AIDS-causing lentivirus, could...

2012-12-10 16:24:00

TITUSVILLE, N.J., Dec. 10, 2012 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a prescribing information update for EDURANT(®) (rilpivirine) tablets to include 96-week pooled data from the Phase 3 ECHO and THRIVE studies, which evaluated the efficacy and safety of EDURANT(®) for the treatment of human immunodeficiency virus type 1 (HIV-1) in antiretroviral treatment-naive adults....

2012-12-05 12:57:18

Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early CVD death in children with HIV Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research1 presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early death from cardiovascular disease. EUROECHO and other Imaging Modalities 2012 is...

2012-12-04 12:18:33

Using computational techniques, researchers have shown how a protein responsible for the maturation of the virus releases itself to initiate infection Bioinformaticians at IMIM (Hospital del Mar Medical Research Institute) and UPF (Pompeu Fabra University) have used molecular simulation techniques to explain a specific step in the maturation of the HIV virions, i.e., how newly formed inert virus particles become infectious, which is essential in understanding how the virus replicates....


Latest Antiretroviral drug Reference Libraries

0_a4499f7c8759b5cbe79bad5eca319070
2011-01-26 14:08:59

Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...

More Articles (1 articles) »